News & Media

  • 07 November 2018

    NeoDynamics featured in FirstWord MedTech

    Read the article here [English].

  • 06 November 2018

    NeoDynamics participates in investor meetings during the IPO

    Read more here [English]

  • 06 November 2018

    NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK

    Read more here [English]

  • 31 October 2018 - Press release

    The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today

    Read the full press release here [English] or here [Swedish]. More information on the IPO can be found here.

  • 30 October 2018 - Press release

    NeoDynamics announces approval on passportation of prospectus

    Read the full press release here [English] or here [Swedish].

  • 29 October 2018 - Press release

    NeoDynamics publishes prospectus and enters agreement on additional subscription commitment

    Read the full press release here [English] or here [Swedish].

  • 25 October 2018 - Press release

    NeoDynamics approved for listing on Spotlight Stock Market

    Read the full press release here [English] or here [Swedish].

  • 19 September 2018

    Market listing

    A market listing of Neoynamics shares is planned for Q4 this year. Subsciption starts in October. Further information will be published later. For more informtion about our IPO please contact us.

  • 21 November 2017

    NeoDynamics receives VINNOVA grant

    The Swedish Innovation Agency (VINNOVA) awarded NeoDynamics a grant of 200.000 SEK for regulatory support to enter the US market. Read more here (Swedish).

  • 24 October 2017

    Carnegie interview with CEO Anna Eriksrud

    Nordic investment bank Carnegie interviewed NeoDynamics CEO Anna Eriksrud on the background of NeoDynamics, future plans and financing needs. Read the interview here (Swedish).

  • 16 October 2017

    Scientific article on NeoNavia Biopsy System

    Details on development and results of preclinical testing of the NeoNavia biopsy system have been submitted as a scientific manuscript titled Development and preclinical validation of a new percutaneous biopsy device to the scientific journal Physica Medica: European Journal of Medical Physics. Click here to see the publication.

  • 10 October 2017

    Research poster presentation on NeoNavia Biopsy System at BSBR 2017 in Dublin

    At the Annual Scientific Meeting of the British Society of Breast Radiology, 5-7 November in Dublin, radiologist from The Royal Marsden in London will be presenting a poster titled NeoNavia biopsy system: Our experience of a new device for more precise ultrasound-guided percutaneous core biopsy of axillary lymph nodes. Click here to see the poster.

“Our innovative medical solutions are designed to help physicians better diagnose and treat cancer, thereby enhancing patient care and saving lives.”

Anna Eriksrud, CEO, NeoDynamics: